Modulation of Heparin-binding Epidermal Growth Factor Activity for Tympanic Membrane Healing
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Inhibition of HB-EGF
[0107]HB-EGF is critical to epidermal wound healing in a tympanic membrane model. The normalized signal intensity of HB-EGF like growth factor following perforation of the tympanic membrane in rats shows an 8.5 fold up regulation of HB-EGF like growth factor. Experimental inhibition of HB-EGF activity is shown herein to prevent a tympanic membrane perforation from healing.
[0108]EGFR Ligand Shedding can be Inhibited to Create a Chronic Tympanic Membrane Perforation Model.
[0109]Subtotal perforations were created in the pars tensa of TMs in 20 mice using a curved needle. OSU8.1 (10 mM), a selective HB-EGF inhibitor (see Tokumaru et al. (2000) J. Cell Biol.), was injected onto gel foam (placed through and onto the perforation) over seven days. Mice were sacrificed at time points (Day 2, 7,14,30,44,60 and 90) to observe the effects on keratinocyte migration. The contralateral ear was used as a control with saline placed onto gel foam. All of these were closed within 2...
example 2
Treatment of Chronic Tympanic Membrane Perforation
[0113]The efficacy of HB-EGF treatment for chronic TM perforations is demonstrated.
[0114]A Biocompatible Absorbable Injectable Polymer for Growth Factor Delivery in Ear Canal. To treat chronic TM perforation, it is desirable to have a liquid that can be dropped into the ear, which then hardens and slowly resorbs over the designated time frame while eluting out the medication. The degradation rate of the polymer and drug eluting rate are readily adjustable according to target of interest.
[0115]A biodegradable chitosan-based hydrogel for delivering growth factors was developed to provide a biocompatible, bioresorbable, injectable polymer that can carry a drug of choice and then can be instilled into the ear canal. The gel has two liquid components and can solidify within a few minutes after mixing the two components. This can be readily administered by a dual-bore syringe. Alternatively the solutions can be mixed with a cross-linking a...
example 3
[0128]A trans-tympanic method of delivery (FIGS. 5, 6 and 7). The vehicle for HB-EGF or HB-EGF delivery is placed against or through the tympanic membrane inserted either trans-canal or via the Eustachian tube. It can be removed after a period of time, or can be biodegradable. The vehicle may contain a design to restrain it within the tympanic membrane. This may be a collar, cuff, flange, groove or any change in width or height. It may have more than one of these to hold it in place. The vehicle may be perforated or have a lumen of any suitable dimension. There may be any number of flanges or any width and dimensions that are deemed sufficient or in excess of that required for the vehicle to be retained in the tympanic membrane.
[0129]Depicted in FIG. 5 is the ear canal 100; external ear 110; and tympanic membrane 120. A transmembrane drug delivery device 125 is also depicted, which has a width 130 and length 140.
[0130]Depicted in FIG. 6 is an alternative embodiment of a trans-tympan...
PUM
Property | Measurement | Unit |
---|---|---|
Time | aaaaa | aaaaa |
Time | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com